News

Filter

Current filters:

Roche

1 to 9 of 4126 results

Celldex collaborates with Roche on varlilumab/APDL3280A combination trial

Celldex collaborates with Roche on varlilumab/APDL3280A combination trial

18-03-2015

Immunotherapy specialist Celldex Therapeutics has entered into a clinical trial collaboration with Roche…

Celldex TherapeuticsOncologyPharmaceuticalResearchRochevarlilumab

NICE says ‘yes’ to new blood cancer drug from Roche

NICE says ‘yes’ to new blood cancer drug from Roche

11-03-2015

Patients in England and Wales with chronic lymphocytic leukemia (CLL) could soon benefit from Gazyvaro…

BiotechnologyGazyvaroOncologyPricingRegulationRocheUK

Indian government caught unawares over flu pandemic

Indian government caught unawares over flu pandemic

09-03-2015

The recent outbreak of infections and death caused by the influenza A H1N1 strain across India has turned…

Anti-viralsGlaxoSmithKlineHealthcareIndiaMarkets & MarketingPharmaceuticalPoliticsRelenzaRocheTamiflu

Bristol-Myers will lead immuno-oncology market in 2022, say analysts

Bristol-Myers will lead immuno-oncology market in 2022, say analysts

04-03-2015

Analysts at Morningstar Equity Research see significantly more opportunity than the overall market for…

AstraZenecaBiotechnologyBristol-Myers SquibbMarkets & MarketingMerck & CoOncologyOpdivoResearchRoche

EMA/CHMP backs Roche’s Avastin plus chemotherapy in advanced cervical cancer

EMA/CHMP backs Roche’s Avastin plus chemotherapy in advanced cervical cancer

28-02-2015

The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has issued a…

AvastinBiotechnologyEuropeOncologyRegulationRoche

UK doctors call for approval of off-label use of Avastin for wet-AMD

UK doctors call for approval of off-label use of Avastin for wet-AMD

25-02-2015

Doctors in the UK are calling on health ministers and NHS England to intervene to make Swiss pharma giant…

AvastinBiotechnologyHealthcareLucentisNovartisOphthalmicsPricingRegulationRocheUK

1 to 9 of 4126 results

Back to top